|
|
Monday, June 9, 2008
Allergan Buys Dermatology Product
Irvine-based Allergan said Monday that it has entered into an agreement with QLT USA, to purchase the firm's Aczone (dapsone) Gel 5% product, a topical treatment for acne vulgaris. Allergan said it will pay approximately $150M for all assets related to the product, which it said could reach revenues in excess of $75M per year. Aczone is used for treating acne; the product is expected to launch in Q4 of this year. Allergan is a supplier of pharmaceuticals and other health care products.
posted on Monday, June 9, 2008
|
 RSS
 Email
Previous news:
Tuesday, October 14, 2008
Monday, October 13, 2008
Friday, October 10, 2008
Thursday, October 9, 2008
Wednesday, October 8, 2008
|
